Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030 EP News Bureau Dec 11, 2024 GlobalData’s latest report reveals that market growth will primarily be driven by the uptake of new monoclonal antibodies (mAbs),…